Indberetning af lede
Indberetning af ledelsens transaktioner med ALK-Abelló A/S' B-aktier og tilknyttede værdipapirer
04 mars 2024 10h00 HE | ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF): I henhold til artikel 19 i EU-forordning nr. 596/2014 af 16. april 2014 om markedsmisbrug (markedsmisbrugsforordningen), følger hermed indberetning af ledende...
Report on transactio
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
04 mars 2024 10h00 HE | ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKABY / AKBLF): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), ALK-Abelló A/S shall report the...
Ordinær generalforsa
Ordinær generalforsamling i ALK-Abelló A/S den 14. marts 2024
16 févr. 2024 08h00 HE | ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF): Ordinær generalforsamling i ALK-Abelló A/S finder sted torsdag den 14. marts 2024 kl. 16.00 hos ALK-Abelló A/S, Bøge Allé 1, 2970 Hørsholm i henhold til vedhæftede...
Annual General Meeti
Annual General Meeting in ALK-Abelló A/S on 14 March 2024
16 févr. 2024 08h00 HE | ALK Abello
        ALK (ALKB:DC / OMX: ALK B / AKBLF): The Annual General Meeting of ALK-Abelló A/S will take place on Thursday, 14 March 2024 at 4:00 PM (CET) at ALK-Abelló A/S, 1 Bøge Allé, 2970 Hørsholm,...
Indberetning af lede
Indberetning af ledelsens transaktioner med ALK-Abelló A/S' B-aktier og tilknyttede værdipapirer
12 févr. 2024 10h15 HE | ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF): I henhold til artikel 19 i EU forordning nr. 596/2014 af 16. april 2014 om markedsmisbrug (markedsmisbrugsforordningen), følger hermed indberetning af ledende...
Report on transactio
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
12 févr. 2024 10h15 HE | ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), ALK-Abelló A/S shall report the...
Indberetning af lede
Indberetning af ledelsens transaktioner med ALK-Abelló A/S' B-aktier og tilknyttede værdipapirer
12 févr. 2024 05h30 HE | ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF): I henhold til artikel 19 i EU forordning nr. 596/2014 af 16. april 2014 om markedsmisbrug (markedsmisbrugsforordningen), følger hermed indberetning af ledende...
Report on transactio
Report on transactions with ALK-Abelló A/S B-shares and associated securities by managerial staff
12 févr. 2024 05h30 HE | ALK Abello
ALK (ALKB:DC / OMX: ALK B / AKBLF): In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation), ALK-Abelló A/S shall report the...
Annual report 2023:
Annual report 2023: ALK delivers 9% sales growth with profits up 50%
08 févr. 2024 07h35 HE | ALK Abello
08 February 2024 ALK’s (ALKB:DC / OMX: ALK B / AKBLF) Board of Directors has approved the company’s 2023 annual report. Following a robust performance in Q4, full-year results were in line with the...
ALK and McMaster res
ALK and McMaster researchers discover new cell that remembers allergies
07 févr. 2024 14h10 HE | ALK Abello
Researchers with McMaster University and Denmark-based pharmaceutical company ALK-Abelló A/S have made a ground-breaking discovery: a new cell that remembers allergies. The discovery gives...